Personalis Inc (NAS:PSNL)
$ 5.87 -0.39 (-6.23%) Market Cap: 497.15 Mil Enterprise Value: 398.65 Mil PE Ratio: 0 PB Ratio: 2.49 GF Score: 61/100

Personalis Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 09, 2021 / 07:30PM GMT
Release Date Price: $22.31 (+0.72%)
Yuko Oku
Morgan Stanley, Research Division - Research Associate

Thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Yuko Oku, an associate on the life science tools and diagnostics team. It's a pleasure to have Personalis join us today, and representing the company is John West, CEO, Director Co-Founder and President; and CFO, Aaron Tachibana. Before we begin for important disclosures, please see Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

Okay. With -- all right, so to begin, for those that might be new to the Personalis story, John, could you give us a high-level overview of the company and the NeXT platform?

John Stephen West
Personalis, Inc. - Co-Founder, CEO, President & Director

Yes. Be happy to. Thanks very much for having us here today. I'd say just to give you a perspective on it, my whole

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot